Anthony Cadena
Anthony is an immunologist with extensive experience in infectious diseases and immuno-oncology. He has a BA in Human Biology from the University of Virginia and a PhD in Immunology from the University of Pittsburgh School of Medicine where he studied host-pathogen interactions in TB. He completed a postdoc at Harvard Medical School where he worked on HIV cure strategies and the latent viral reservoir. Prior to joining BigHat, Anthony was a Senior Scientist at Tizona Therapeutics where he led monoclonal antibody programs against myeloid targets in the tumor microenvironment.
BigHat Biosciences
Machine Learning and AI Tools to Guide Engineering of Human Therapeutics
-
Join us for an in-depth look at how biotechnology leaders are harnessing machine learning and data-driven approaches to engineer novel human therapeutics right now—well beyond the “someday” promises of AI. In this session, experts from pioneering organizations will share real-world insights into using big data and advanced analytics to accelerate everything from target discovery to clinical development. Discover how these teams are unlocking fresh possibilities for personalized treatments, improving success rates, and shaping the future of human health through powerful, actionable applications of ML and AI.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
